A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos | Journal of Medicinal Chemistry
Controversy regarding the functional conservation of cereblon CUL4-type E3 ligase substrate receptor
Cereblon modulator 1|Cas# 1860875-51-9
A novel cereblon modulator for targeted protein degradation - ScienceDirect
Cereblon E3 ligase modulators (CELMoDs), dBET and their respective... | Download Scientific Diagram
Frontiers | Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine
The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases - ScienceDirect
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase | Nature
Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs | SpringerLink
Target degradation landscape of clinical cereblon modulators. (A) A... | Download Scientific Diagram
A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer - ScienceDirect
The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron | Nature
Rezidiviertes/refraktäres Multiples Myelom: Studie mit neuartigem Cereblon -E3-Ligase-Modulator
Frontiers | Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine
Cereblon modulators: Low molecular weight inducers of protein degradation - ScienceDirect
Cereblon Modulator, Gene | MedChemExpress
Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology - ScienceDirect
CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells - ScienceDirect
Cancers | Free Full-Text | Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma
Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as well as Cell Metabolism and Disease Generation
Cereblon E3 Ligase Modulators – BMS
Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality | ACS Medicinal Chemistry Letters
Nature Portfolio auf Twitter: „A new cereblon modulator, CC-885, has been identified with potent anti-tumour activity https://t.co/fNxZ9K7ON5 https://t.co/FtnQXQ9dFr“ / Twitter
CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia | Journal of Medicinal Chemistry
Frontiers | Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine
A Cereblon Modulator CC-885 Induces CRBN- and p97-Dependent PLK1 Degradation and Synergizes with Volasertib to Suppress Lung Cancer - ScienceDirect
